We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+15.96%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$2.33B
AUM Growth
+$352M
Cap. Flow
+$348M
Cap. Flow %
14.93%
Top 10 Hldgs %
55.33%
Holding
157
New
17
Increased
46
Reduced
30
Closed
20

Sector Composition

Rank Sector Weight
1 Healthcare 38.07%
2 Consumer Discretionary 9.17%
3 Communication Services 4.02%
4 Financials 3.76%
5 Industrials 2.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKUR
126
OnKure Therapeutics
OKUR
$164M
$471K 0.02%
54,777
-3
-0% -$45
EWTX icon
127
Edgewise Therapeutics
EWTX
$4.84B
$357K 0.02%
13,371
PLCE icon
128
Children's Place
PLCE
$58.3M
$307K 0.01%
29,314
LADR
129
Ladder Capital
LADR
$1.22B
$287K 0.01%
25,631
XGN icon
130
Exagen
XGN
$161M
$255K 0.01%
62,116
FBIO icon
131
Fortress Biotech
FBIO
$91.4M
$254K 0.01%
125,520
-27,632
-18% -$50.1K
LUCD icon
132
Lucid Diagnostics
LUCD
$183M
$77.4K ﹤0.01%
94,541
-31,821
-25% -$28.1K
IMTXW
133
DELISTED
Immatics N.V. Warrants
IMTXW
$62.5K ﹤0.01%
248,506
TACT icon
134
Transact Technologies
TACT
$57.6M
$61.5K ﹤0.01%
15,046
-5,077
-25% -$21.3K
GFAIW icon
135
Guardforce AI Warrant
GFAIW
$90K
$54.1K ﹤0.01%
154,205
TCBPW
136
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$2.33K ﹤0.01%
235,294
PERF.WS
137
DELISTED
Perfect Corp Warrants
PERF.WS
$1.38K ﹤0.01%
16,075
CLRB icon
138
Cellectar Biosciences
CLRB
$20.8M
-90,415
Closed -$5.8M
ENVA icon
139
CALL
Enova International
ENVA
$6.29B
-109,000
Closed -$9.13M
GOSS icon
140
Gossamer Bio
GOSS
$86.1M
-672,856
Closed -$664K
LMND.WS
141
DELISTED
Lemonade Inc Warrants
LMND.WS
-507,460
Closed -$16.2K
LOPE icon
142
PUT
Grand Canyon Education
LOPE
$3.82B
-400,000
Closed -$56.7M
LXFR icon
143
Luxfer Holdings
LXFR
$457M
-413,950
Closed -$5.36M
NGNE icon
144
Neurogene
NGNE
$729M
-42,279
Closed -$1.77M
NMTC icon
145
NeuroOne Medical Technologies
NMTC
$13.6M
-133,127
Closed -$791K
RILY icon
146
BRC Group Holdings
RILY
$292M
-136,174
Closed -$715K
TIL icon
147
Instil Bio
TIL
$50.3M
-20,276
Closed -$1.36M
VNDA icon
148
Vanda Pharmaceuticals
VNDA
$304M
-1,593,516
Closed -$7.47M
XBI icon
149
State Street SPDR S&P Biotech ETF
XBI
$10.4B
-21,646
Closed -$2.1M
HURA
150
TuHURA Biosciences
HURA
$137M
-2,279
Closed -$15.6K

Similar funds

Nantahala Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Nantahala Capital Management held 157 positions worth $2.33B, up 18% from $1.98B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Nantahala Capital Management deployed $348M of net new capital in Q4 2024, opening 17 new positions and adding to 46 existing holdings. Its largest new stake was Service Properties Trust: 1,618,380 shares worth $20.6M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Establishment Labs, an estimated $30.7M trimmed.

  • Nantahala Capital Management's largest Q4 2024 buy was Service Properties Trust: 1,618,380 shares worth $20.6M.
  • Nantahala Capital Management added most to Hilton Grand Vacations in Q4 2024, an estimated $38.8M increase.
  • Nantahala Capital Management's biggest Q4 2024 reduction was Establishment Labs, cutting an estimated $30.7M.
  • Nantahala Capital Management fully exited PowerSchool Holdings, Inc. in Q4 2024, selling an estimated $13.3M.
  • Nantahala Capital Management's ten largest holdings make up 55% of its $2.33B portfolio in Q4 2024.
  • Nantahala Capital Management opened 17 new positions and closed 20 in Q4 2024.
  • Nantahala Capital Management's portfolio value rose 18% quarter-over-quarter to $2.33B.

Based on Nantahala Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.